| Titolo |
Pubblicato in |
Anno |
| Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension |
ERJ OPEN RESEARCH |
2022 |
| Peripheral microangiopathy changes in pulmonary arterial hypertension related to systemic sclerosis- data from a multicenter observational study |
FRONTIERS IN CARDIOVASCULAR MEDICINE |
2022 |
| Impact of non-cardiac comorbidities on diastolic properties in HFREF and HFmrEF patients |
EUROPEAN HEART JOURNAL SUPPLEMENTS |
2022 |
| Right Ventricular Strain Curve Morphology and Outcome in Idiopathic Pulmonary Arterial Hypertension |
JACC. CARDIOVASCULAR IMAGING |
2021 |
| The Growing Role of Echocardiography in Pulmonary Arterial Hypertension Risk Stratification: The Missing Piece |
JOURNAL OF CLINICAL MEDICINE |
2021 |
| Peripheral arterial stiffness in acute pulmonary embolism and pulmonary hypertension at short-term follow-up |
JOURNAL OF CLINICAL MEDICINE |
2021 |
| Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension |
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE |
2021 |
| Right ventricular assessment matters for precision medicine. Reply to "Identifying parameters associated with response to switching from a PDE5i to riociguat in RESPITE" |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2021 |
| Incidence and long-term outcomes of pregnant women complicated with pulmonary arterial hypertension during different pregnancies. a prospective cohort study from china |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2021 |
| Right ventricular strain in pulmonary hypertension looking at the small print reply |
JACC. CARDIOVASCULAR IMAGING |
2021 |
| Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH Solution): proposal of a study protocol aimed to realize a validated risk score for early diagnosis |
MINERVA CARDIOLOGY AND ANGIOLOGY |
2021 |
| Multidimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping |
THE JOURNAL OF HEART AND LUNG TRANSPLANTATION |
2021 |
| Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis |
THE JOURNAL OF HEART AND LUNG TRANSPLANTATION |
2020 |
| Usefulness of adding echocardiography of the right heart to risk-assessment scores in prostanoid-treated pulmonary arterial hypertension |
JACC: CARDIOVASCULAR IMAGING |
2020 |
| Intra-aortic balloon counterpulsation timing: A new numerical model for programming and training in the clinical environment |
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE |
2020 |
| Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension |
CHEST |
2020 |
| Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension. |
THE JOURNAL OF HEART AND LUNG TRANSPLANTATION |
2020 |
| Risk reduction and hemodynamics with initial combination theraphy in pulmonary arterial hypertension |
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE |
2020 |
| Multidimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping. |
THE JOURNAL OF HEART AND LUNG TRANSPLANTATION |
2020 |
| The importance of right ventricular evaluation in risk assessment and therapeutic strategies: raising the bar in pulmonary arterial hypertension |
INTERNATIONAL JOURNAL OF CARDIOLOGY |
2020 |
